Navigation Links
Major Physician Group Issues Statement in Support of Physician/Industry Relationships
Date:5/15/2009

HOUSTON, May 15 /PRNewswire-USNewswire/ -- The American Association of Clinical Endocrinologists and the American College of Endocrinology (AACE and ACE) today released a Position Statement on Physician/Industry Relationships. The position is a strong statement in support of continuing the beneficial and ethical collaboration between physicians and industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090324/DC88061LOGO-b)

The statement, shown below in its entirety, was released at the AACE 18th Annual Meeting and Clinical Congress in Houston.

"The American Association of Clinical Endocrinologists and The American College of Endocrinology (AACE and ACE) believe that interaction between physicians and industry has contributed to safe, effective, and value- oriented health care. AACE and ACE affirm that relationships between physicians and industry have been overwhelmingly consistent with ethical standards and responsive to the needs of patients.

There is no inherent conflict of interest in the working relationship of physicians with industry and government. Rather, there is a commonality of interest that is healthy, desirable, and beneficial. The collaborative and constructive relationship among physicians, government, and industry has resulted in many medical advancements and improved health outcomes.

Since their inception, AACE and ACE have formulated policies and procedures to guide the conduct of the organizations and their members in cooperative interactions with industry and with government. These policies are continually being updated to reflect the changing practice and health care environment. AACE and ACE are committed to preserving relationships, including those with industry and with government, that contribute to the fulfillment of their basic mission: to enhance physicians' ability to provide the highest quality of medical care for patients with endocrine disorders."

-AACE and ACE Position Statement on Physician/Industry Relationships

May 15, 2009

"Physician and industry collaboration has advanced the treatment of major illnesses such as diabetes, heart disease, osteoporosis, high cholesterol and hypertension," said Daniel Duick, MD, FACP FACE, and President of the AACE. "The overwhelming majority of physicians, in all fields of healthcare, evaluate and apply advances that are deemed effective, safe and result in best clinical practice outcomes; and, they do so with their patients in mind, and not for pharmaceutical perks."

The Position Statement will be published in the May/June issue of Endocrine Practice, the Journal of the American Association of Clinical Endocrinologists.

To view a copy of the AACE and ACE policies and procedures regarding the disclosure of conflicts of interest, please click here.

For more information on the AACE 18th Annual Meeting and Clinical Congress, click here.

A short, one page bio and high resolution photo of AACE President Daniel Duick, MD, FACP, FACE, are available here.

About AACE

AACE is a professional medical organization with more than 6,200 members in the United States and 92 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine disorders. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine diseases, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.


'/>"/>
SOURCE American Association of Clinical Endocrinologists
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
2. Laboratory at UI plays major role in diagnosing cancer
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
5. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
6. Major grant advances UWs clinical and translational research enterprise
7. Major differences revealed in how local authorities in the UK support disabled people
8. Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season
9. Worldwide Probiotic Drink, Yakult(R), Launches in Its First Major U.S. Market
10. Ericom Provides Significant Cost-Savings for Major New York City Healthcare Organization
11. Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... Like jewels in a crown, the ... – London is home to Ontario’s leading day spa and one of Canada’s few ... began with a unique concept to combine spa services with hair and beauty ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... WaterField Designs, ... digital-minded professionals, announces the waxed-canvas and leather Duo Dopp Kit , the ideal ... canvas or ballistic nylon, the Duo is smartly designed for Dad’s grooming ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Spectrum Aquatics has ... new lift has been designed and built with the user in mind. , “Over ... consultants have informed us that an ADA 400 lbs lift is a necessary requirement ...
(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... Interest ... a primary screening tool and as an orthogonal tool for RNAi hit validation. A ... functional and specific guide RNAs—allows rapid generation of CRISPR RNA (crRNA) collections in arrayed ...
(Date:5/31/2016)... ... May 31, 2016 , ... TeaZa® Energy, LLC announces ... on World No Tobacco Day . The new flavor—Tropical TeaZa? Energy—will be ... this summer. , The new flavor is best described as a juicy, taste ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 2016 Since its commercial introduction ... essential life science tool for conducting genetic studies in ... reveals in its new report that the industry sits ... powered by a range of new applications in the ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
(Date:5/25/2016)... , May 25, 2016 As ... Expo earlier this month, the numbers and momentum of ... to climb into the billions, more research and development ... 4th Edition State of Legal Marijuana Markets Report  from ... data-analysis firm, much of the increase in sector is ...
Breaking Medicine Technology: